410 related articles for article (PubMed ID: 3571981)
1. Immunologic response to the influenza virus neuraminidase is influenced by prior experience with the associated viral hemagglutinin. I. Studies in human vaccinees.
Kilbourne ED; Cerini CP; Khan MW; Mitchell JW; Ogra PL
J Immunol; 1987 May; 138(9):3010-3. PubMed ID: 3571981
[TBL] [Abstract][Full Text] [Related]
2. Immunologic response to influenza virus neuraminidase is influenced by prior experience with the associated viral hemagglutinin. II. Sequential infection of mice simulates human experience.
Johansson BE; Moran TM; Bona CA; Popple SW; Kilbourne ED
J Immunol; 1987 Sep; 139(6):2010-4. PubMed ID: 3624874
[TBL] [Abstract][Full Text] [Related]
3. Immunologic response to influenza virus neuraminidase is influenced by prior experience with the associated viral hemagglutinin. III. Reduced generation of neuraminidase-specific helper T cells in hemagglutinin-primed mice.
Johansson BE; Moran TM; Bona CA; Kilbourne ED
J Immunol; 1987 Sep; 139(6):2015-9. PubMed ID: 2957444
[TBL] [Abstract][Full Text] [Related]
4. Immunization with dissociated neuraminidase, matrix, and nucleoproteins from influenza A virus eliminates cognate help and antigenic competition.
Johansson BE; Kilbourne ED
Virology; 1996 Nov; 225(1):136-44. PubMed ID: 8918540
[TBL] [Abstract][Full Text] [Related]
5. Immunization against influenza A virus: comparison of conventional inactivated, live-attenuated and recombinant baculovirus produced purified hemagglutinin and neuraminidase vaccines in a murine model system.
Brett IC; Johansson BE
Virology; 2005 Sep; 339(2):273-80. PubMed ID: 15996702
[TBL] [Abstract][Full Text] [Related]
6. Clinical evaluation of neuraminidase monospecific (HEqN2) recombinant influenza vaccine in children.
Beutner KR; Rizzone C; DeMello S; Ogra PL
Dev Biol Stand; 1976; 33():162-70. PubMed ID: 782964
[TBL] [Abstract][Full Text] [Related]
7. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
Walter EB; Neuzil KM; Zhu Y; Fairchok MP; Gagliano ME; Monto AS; Englund JA
Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948
[TBL] [Abstract][Full Text] [Related]
8. Beta 2-microglobulin-deficient mice can be protected against influenza A infection by vaccination with vaccinia-influenza recombinants expressing hemagglutinin and neuraminidase.
Epstein SL; Misplon JA; Lawson CM; Subbarao EK; Connors M; Murphy BR
J Immunol; 1993 Jun; 150(12):5484-93. PubMed ID: 8390536
[TBL] [Abstract][Full Text] [Related]
9. Antibody responses to inactivated influenza vaccines and partial protective effect of anti-neuraminidase antibody against epidemics of A(H3N2) and A(H1N1) influenza.
Maeda A; Oishi I; Minekawa Y; Kunita N; Funahashi S; Yagura H
Biken J; 1979 Sep; 22(3):91-8. PubMed ID: 533537
[No Abstract] [Full Text] [Related]
10. [Enhancement of the immune response to surface antigens of the influenza B virus as a result of their covalent binding with a synthetic polymer carrier].
Petrov RV; Zhdanov VM; Kabanov VA; Khaitov RM; Norimov ASh
Biull Eksp Biol Med; 1985 Feb; 99(2):184-6. PubMed ID: 4038611
[TBL] [Abstract][Full Text] [Related]
11. Immunity to influenza.
Schild GC; Oxford JS; Virelizier JL
Dev Biol Stand; 1975; 28():253-72. PubMed ID: 47824
[TBL] [Abstract][Full Text] [Related]
12. Clinical trials with a new influenza subunit vaccine in adults and children.
Kunz C; Hofmann H; Bachmayer H; Liehl E; Moritz AJ
Dev Biol Stand; 1977 Jun 1-3; 39():297-302. PubMed ID: 342311
[TBL] [Abstract][Full Text] [Related]
13. Influenza viral neuraminidase: the forgotten antigen.
Johansson BE; Cox MM
Expert Rev Vaccines; 2011 Dec; 10(12):1683-95. PubMed ID: 22085172
[TBL] [Abstract][Full Text] [Related]
14. [Antibody response to hemagglutinin and neuraminidase induced by an influenza subunit vaccine (author's transl)].
Kuwert E; Werner J; Franke G; Paulus W
Zentralbl Bakteriol Orig A; 1979 Jun; 244(1):1-16. PubMed ID: 92113
[TBL] [Abstract][Full Text] [Related]
15. Neuraminidase antibody response to inactivated influenza virus vaccine following intranasal and intramuscular vaccination.
Muhamed G; Greenbaum E; Zakay-Rones Z
Isr Med Assoc J; 2006 Mar; 8(3):155-8. PubMed ID: 16599048
[TBL] [Abstract][Full Text] [Related]
16. Potentiation of the immune response to influenza virus subunit vaccines.
Webster RG; Glezen WP; Kasel JA; Laver WG
Dev Biol Stand; 1977 Jun 1-3; 39():243-8. PubMed ID: 604104
[TBL] [Abstract][Full Text] [Related]
17. Vaccination of an adolescent group with A (H3N2) + A(HSW1N1) bivaccine before an A (H1N1) influenza epidemic.
Stumpa A; Cihla F; Tůmová B; Husek V; Slezácek J
Acta Virol; 1979 Sep; 23(5):443-5. PubMed ID: 42307
[TBL] [Abstract][Full Text] [Related]
18. Purified viral neuraminidase vaccine to control influenza.
Arora DJ
Can Med Assoc J; 1979 Dec; 121(12):1575-9. PubMed ID: 394829
[TBL] [Abstract][Full Text] [Related]
19. A practical influenza neutralization assay to simultaneously quantify hemagglutinin and neuraminidase-inhibiting antibody responses.
Hassantoufighi A; Zhang H; Sandbulte M; Gao J; Manischewitz J; King L; Golding H; Straight TM; Eichelberger MC
Vaccine; 2010 Jan; 28(3):790-7. PubMed ID: 19887135
[TBL] [Abstract][Full Text] [Related]
20. Generation and evaluation of the trivalent inactivated reassortant vaccine using human, avian, and swine influenza A viruses.
Du N; Li W; Li Y; Liu S; Sui Y; Qu Z; Wang Y; Du Y; Xu B
Vaccine; 2008 Jun; 26(23):2912-8. PubMed ID: 18448208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
